{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:24:55Z","timestamp":1789874695118,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis E virus (HEV), rotavirus (RV), and astrovirus (AstV) are important pathogens that transmit through a common fecal-oral route, causing hepatitis (HEV) and gastroenteritis (RV and AstV) respectively in humans. In this study, we developed and evaluated two subunit vaccine candidates that consisted of the same protruding or spike protein antigens of the three viruses in two formats, a fusion of the three antigens into one molecule (fused vaccine) vs. a mixture of the three free antigens together (mixed vaccine). Both vaccines were easily made via<jats:italic>E. coli<\/jats:italic>expression system. Mouse immunization experiments showed that the fused vaccine elicited significantly higher antibody responses against the three viral antigens than those induced by the mixed vaccine. In addition, the mouse post-immune antisera of the fused vaccine revealed significantly higher neutralizing titers against HEV infection in cell culture, as well as significantly higher 50% blocking titers (BT<jats:sub>50<\/jats:sub>) against RV VP8-HBGA receptor interactions than those of the post-immune antisera after immunization of the mixed vaccine. Thus, the fused vaccine is a promising trivalent vaccine candidate against HEV, RV, and AstV, which is worth for further development.<\/jats:p>","DOI":"10.1038\/srep25735","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T20:21:17Z","timestamp":1463775677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus"],"prefix":"10.1038","volume":"6","author":[{"given":"Ming","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"BFsrep25735_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmv.522","volume":"17","author":"SK Panda","year":"2007","unstructured":"Panda, S. K., Thakral, D. & Rehman, S. Hepatitis E virus. Reviews in medical virology 17, 151\u2013180 (2007).","journal-title":"Reviews in medical virology"},{"key":"BFsrep25735_CR2","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/j.ijid.2012.11.026","volume":"17","author":"S Kumar","year":"2013","unstructured":"Kumar, S., Subhadra, S., Singh, B. & Panda, B. K. Hepatitis E virus: the current scenario. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 17, e228\u2013233 (2013).","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"key":"BFsrep25735_CR3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095\u20132128 (2012).","journal-title":"Lancet"},{"key":"BFsrep25735_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-3-7091-6553-9_31","volume":"12","author":"RI Glass","year":"1996","unstructured":"Glass, R. I. et al. The changing epidemiology of astrovirus-associated gastroenteritis: a review. Archives of virology. Supplementum 12, 287\u2013300 (1996).","journal-title":"Archives of virology. Supplementum"},{"key":"BFsrep25735_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","volume":"12","author":"JE Tate","year":"2012","unstructured":"Tate, J. E. et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12, 136\u2013141 (2012).","journal-title":"Lancet Infect Dis"},{"key":"BFsrep25735_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0470846534.ch2","volume":"238","author":"RI Glass","year":"2001","unstructured":"Glass, R. I. et al. Gastroenteritis viruses: an overview. Novartis Found Symp 238, 5\u201319; discussion 19\u201325 (2001).","journal-title":"Novartis Found Symp"},{"key":"BFsrep25735_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00001432-200306000-00011","volume":"16","author":"JE Walter","year":"2003","unstructured":"Walter, J. E. & Mitchell, D. K. Astrovirus infection in children. Current opinion in infectious diseases 16, 247\u2013253 (2003).","journal-title":"Current opinion in infectious diseases"},{"key":"BFsrep25735_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.meegid.2011.07.024","volume":"11","author":"P De Benedictis","year":"2011","unstructured":"De Benedictis, P., Schultz-Cherry, S., Burnham, A. & Cattoli, G. Astrovirus infections in humans and animals - molecular biology, genetic diversity, and interspecies transmissions. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 11, 1529\u20131544 (2011).","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"BFsrep25735_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3201\/eid0505.990502","volume":"5","author":"PS Mead","year":"1999","unstructured":"Mead, P. S. et al. Food-related illness and death in the United States. Emerg Infect Dis 5, 607\u2013625 (1999).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep25735_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3201\/eid1606.091536","volume":"16","author":"PL Quan","year":"2010","unstructured":"Quan, P. L. et al. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis 16, 918\u2013925 (2010).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep25735_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/cid\/ciu912","volume":"60","author":"SN Naccache","year":"2015","unstructured":"Naccache, S. N. et al. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis 60, 919\u2013923 (2015).","journal-title":"Clin Infect Dis"},{"key":"BFsrep25735_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/cid\/ciu940","volume":"60","author":"JR Brown","year":"2015","unstructured":"Brown, J. R. et al. Astrovirus VA1\/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients. Clin Infect Dis 60, 881\u2013888 (2015).","journal-title":"Clin Infect Dis"},{"key":"BFsrep25735_CR13","doi-asserted-by":"publisher","first-page":"33175","DOI":"10.1074\/jbc.M110.106336","volume":"285","author":"L Xing","year":"2010","unstructured":"Xing, L. et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. The Journal of biological chemistry 285, 33175\u201333183 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep25735_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jmb.2012.06.029","volume":"422","author":"KA Dryden","year":"2012","unstructured":"Dryden, K. A. et al. Immature and mature human astrovirus: structure, conformational changes, and similarities to hepatitis E virus. J Mol Biol 422, 650\u2013658 (2012).","journal-title":"J Mol Biol"},{"key":"BFsrep25735_CR15","doi-asserted-by":"publisher","first-page":"e1000537","DOI":"10.1371\/journal.ppat.1000537","volume":"5","author":"S Li","year":"2009","unstructured":"Li, S. et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. Plos pathogens 5, e1000537 (2009).","journal-title":"Plos pathogens"},{"key":"BFsrep25735_CR16","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1128\/JVI.03139-12","volume":"87","author":"RM DuBois","year":"2013","unstructured":"DuBois, R. M. et al. Crystal structure of the avian astrovirus capsid spike. J Virol 87, 7853\u20137863 (2013).","journal-title":"J Virol"},{"key":"BFsrep25735_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/343476a0","volume":"343","author":"BV Prasad","year":"1990","unstructured":"Prasad, B. V., Burns, J. W., Marietta, E., Estes, M. K. & Chiu, W. Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature 343, 476\u2013479 (1990).","journal-title":"Nature"},{"key":"BFsrep25735_CR18","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/erm.2014.2","volume":"16","author":"M Tan","year":"2014","unstructured":"Tan, M. & Jiang, X. Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med 16, e5 (2014).","journal-title":"Expert Rev Mol Med"},{"key":"BFsrep25735_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/0-387-33026-7_5","volume":"582","author":"RI Glass","year":"2006","unstructured":"Glass, R. I. et al. Rotavirus and rotavirus vaccines. Advances in experimental medicine and biology 582, 45\u201354 (2006).","journal-title":"Advances in experimental medicine and biology"},{"key":"BFsrep25735_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0140-6736(06)68815-6","volume":"368","author":"RI Glass","year":"2006","unstructured":"Glass, R. I. et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368, 323\u2013332 (2006).","journal-title":"Lancet"},{"key":"BFsrep25735_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","volume":"376","author":"K Zaman","year":"2010","unstructured":"Zaman, K. et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376, 615\u2013623 (2010).","journal-title":"Lancet"},{"key":"BFsrep25735_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJMoa0904797","volume":"362","author":"SA Madhi","year":"2010","unstructured":"Madhi, S. A. et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362, 289\u2013298 (2010).","journal-title":"N Engl J Med"},{"key":"BFsrep25735_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","volume":"376","author":"GE Armah","year":"2010","unstructured":"Armah, G. E. et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376, 606\u2013614 (2010).","journal-title":"Lancet"},{"key":"BFsrep25735_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/INF.0b013e318270362c","volume":"32","author":"R Desai","year":"2013","unstructured":"Desai, R. et al. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. The Pediatric infectious disease journal 32, 1\u20137 (2013).","journal-title":"The Pediatric infectious disease journal"},{"key":"BFsrep25735_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/pds.3800","volume":"24","author":"V Bauchau","year":"2015","unstructured":"Bauchau, V. et al. Post-marketing monitoring of intussusception after rotavirus vaccination in Japan. Pharmacoepidemiology and drug safety 24, 765\u2013770 (2015).","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"BFsrep25735_CR26","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.jpeds.2015.03.038","volume":"167","author":"C-F Yung","year":"2015","unstructured":"Yung, C.-F., Chan, S. P., Soh, S., Tan, A. & Thoon, K. C. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study. The Journal of pediatrics 167, 163\u2013168. e161 (2015).","journal-title":"The Journal of pediatrics"},{"key":"BFsrep25735_CR27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/INF.0000000000000715","volume":"34","author":"D Rosillon","year":"2015","unstructured":"Rosillon, D. et al. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies. The Pediatric infectious disease journal 34, 763\u2013768 (2015).","journal-title":"The Pediatric infectious disease journal"},{"key":"BFsrep25735_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1303164","volume":"370","author":"WK Yih","year":"2014","unstructured":"Yih, W. K. et al. Intussusception risk after rotavirus vaccination in U.S. infants. The New England journal of medicine 370, 503\u2013512 (2014).","journal-title":"The New England journal of medicine"},{"key":"BFsrep25735_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1311738","volume":"370","author":"ES Weintraub","year":"2014","unstructured":"Weintraub, E. S. et al. Risk of intussusception after monovalent rotavirus vaccination. The New England journal of medicine 370, 513\u2013519 (2014).","journal-title":"The New England journal of medicine"},{"key":"BFsrep25735_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMe1315836","volume":"370","author":"RI Glass","year":"2014","unstructured":"Glass, R. I. & Parashar, U. D. Rotavirus vaccines\u2013balancing intussusception risks and health benefits. The New England journal of medicine 370, 568\u2013570 (2014).","journal-title":"The New England journal of medicine"},{"key":"BFsrep25735_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nbt0412-300a","volume":"30","author":"A Proffitt","year":"2012","unstructured":"Proffitt, A. & First, H. E. V. vaccine approved. Nature Biotechnology 30, 300 (2012).","journal-title":"Nature Biotechnology"},{"key":"BFsrep25735_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.tibtech.2013.09.002","volume":"31","author":"Q Zhao","year":"2013","unstructured":"Zhao, Q., Li, S., Yu, H., Xia, N. & Modis, Y. Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends in biotechnology 31, 654\u2013663 (2013).","journal-title":"Trends in biotechnology"},{"key":"BFsrep25735_CR33","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","volume":"23","author":"SW Li","year":"2005","unstructured":"Li, S. W. et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23, 2893\u20132901 (2005).","journal-title":"Vaccine"},{"key":"BFsrep25735_CR34","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.vaccine.2009.11.016","volume":"28","author":"H Sellers","year":"2010","unstructured":"Sellers, H., Linneman, E., Icard, A. H. & Mundt, E. A purified recombinant baculovirus expressed capsid protein of a new astrovirus provides partial protection to runting-stunting syndrome in chickens. Vaccine 28, 1253\u20131263 (2010).","journal-title":"Vaccine"},{"key":"BFsrep25735_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.vaccine.2015.12.068","volume":"34","author":"M Xia","year":"2016","unstructured":"Xia, M. et al. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus. Vaccine 34, 905\u2013913 (2016).","journal-title":"Vaccine"},{"key":"BFsrep25735_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/03079457.2013.822467","volume":"42","author":"A Lee","year":"2013","unstructured":"Lee, A. et al. Chicken astrovirus capsid proteins produced by recombinant baculoviruses: potential use for diagnosis and vaccination. Avian pathology: journal of the W. V. P. A 42, 434\u2013442 (2013).","journal-title":"Avian pathology: journal of the W. V. P. A"},{"key":"BFsrep25735_CR37","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1016\/j.biomaterials.2013.02.041","volume":"34","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. Polyvalent complexes for vaccine development. Biomaterials 34, 4480\u20134492 (2013).","journal-title":"Biomaterials"},{"key":"BFsrep25735_CR38","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.1016\/j.biomaterials.2014.06.021","volume":"35","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. Branched-linear and agglomerate protein polymers as vaccine platforms. Biomaterials 35, 8427\u20138438 (2014).","journal-title":"Biomaterials"},{"key":"BFsrep25735_CR39","doi-asserted-by":"publisher","first-page":"8346","DOI":"10.1038\/ncomms9346","volume":"6","author":"L Hu","year":"2015","unstructured":"Hu, L. et al. Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nat Commun 6, 8346 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep25735_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.virol.2008.08.047","volume":"382","author":"M Tan","year":"2008","unstructured":"Tan, M. et al. Noroviral P particle: Structure, function and applications in virus-host interaction. Virology 382, 115\u2013123 (2008).","journal-title":"Virology"},{"key":"BFsrep25735_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1128\/JVI.01835-10","volume":"85","author":"M Tan","year":"2011","unstructured":"Tan, M. et al. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 85, 753\u2013764 (2011).","journal-title":"J Virol"},{"key":"BFsrep25735_CR42","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1128\/JVI.05507-11","volume":"86","author":"P Huang","year":"2012","unstructured":"Huang, P. et al. Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol 86, 4833\u20134843 (2012).","journal-title":"J Virol"},{"key":"BFsrep25735_CR43","doi-asserted-by":"publisher","first-page":"9899","DOI":"10.1128\/JVI.00979-12","volume":"86","author":"Y Liu","year":"2012","unstructured":"Liu, Y. et al. Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol 86, 9899\u20139910 (2012).","journal-title":"J Virol"},{"key":"BFsrep25735_CR44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature10996","volume":"485","author":"L Hu","year":"2012","unstructured":"Hu, L. et al. Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485, 256\u2013259 (2012).","journal-title":"Nature"},{"key":"BFsrep25735_CR45","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/JCM.02927-13","volume":"52","author":"N Van Trang","year":"2014","unstructured":"Van Trang, N. et al. Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. Journal of clinical microbiology 52, 1366\u20131374 (2014).","journal-title":"Journal of clinical microbiology"},{"key":"BFsrep25735_CR46","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jit655","volume":"209","author":"B-M Imbert-Marcille","year":"2014","unstructured":"Imbert-Marcille, B.-M. et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. The Journal of infectious diseases 209, 1227\u20131230 (2014).","journal-title":"The Journal of infectious diseases"},{"key":"BFsrep25735_CR47","doi-asserted-by":"crossref","unstructured":"Xia, M., Wei, C., Wang, L. Y., Cao, D. J., Meng, X. J., Jiang, X. & Tan, M. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus. Vaccine in press (2016).","DOI":"10.1016\/j.vaccine.2015.12.068"},{"key":"BFsrep25735_CR48","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","volume":"65","author":"CR Casella","year":"2008","unstructured":"Casella, C. R. & Mitchell, T. C. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cellular and molecular life sciences: CMLS 65, 3231\u20133240 (2008).","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"BFsrep25735_CR49","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","volume":"365","author":"RL Atmar","year":"2011","unstructured":"Atmar, R. L. et al. Norovirus vaccine against experimental human Norwalk Virus illness. The New England journal of medicine 365, 2178\u20132187 (2011).","journal-title":"The New England journal of medicine"},{"key":"BFsrep25735_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.virusres.2011.03.015","volume":"161","author":"Y Mori","year":"2011","unstructured":"Mori, Y. & Matsuura, Y. Structure of hepatitis E viral particle. Virus research 161, 59\u201364 (2011).","journal-title":"Virus research"},{"key":"BFsrep25735_CR51","doi-asserted-by":"crossref","unstructured":"Ahmad, I., Holla, R. P. & Jameel, S. Molecular virology of hepatitis E virus. Virus Res 161, 47\u201358.","DOI":"10.1016\/j.virusres.2011.02.011"},{"key":"BFsrep25735_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.vaccine.2013.11.064","volume":"32","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine 32, 445\u2013452 (2014).","journal-title":"Vaccine"},{"key":"BFsrep25735_CR53","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1128\/JVI.78.12.6233-6242.2004","volume":"78","author":"M Tan","year":"2004","unstructured":"Tan, M., Hegde, R. S. & Jiang, X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol 78, 6233\u20136242 (2004).","journal-title":"J Virol"},{"key":"BFsrep25735_CR54","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","volume":"79","author":"M Tan","year":"2005","unstructured":"Tan, M. & Jiang, X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 79, 14017\u201314030 (2005).","journal-title":"J Virol"},{"key":"BFsrep25735_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.virol.2010.11.017","volume":"410","author":"M Tan","year":"2011","unstructured":"Tan, M. et al. Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology 410, 345\u2013352 (2011).","journal-title":"Virology"},{"key":"BFsrep25735_CR56","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1099\/vir.0.81545-0","volume":"87","author":"SU Emerson","year":"2006","unstructured":"Emerson, S. U. et al. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. The Journal of general virology 87, 697\u2013704 (2006).","journal-title":"The Journal of general virology"},{"key":"BFsrep25735_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/tbed.12001","volume":"60","author":"BJ Sanford","year":"2013","unstructured":"Sanford, B. J. et al. Serological evidence for a hepatitis e virus-related agent in goats in the United States. Transboundary and emerging diseases 60, 538\u2013545 (2013).","journal-title":"Transboundary and emerging diseases"},{"key":"BFsrep25735_CR58","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","volume":"79","author":"M Tan","year":"2005","unstructured":"Tan, M. & Jiang, X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. Journal of Virology 79, 14017\u201314030 (2005).","journal-title":"Journal of Virology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep25735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25735","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T18:35:10Z","timestamp":1718562910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep25735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,27]]}},"alternative-id":["BFsrep25735"],"URL":"https:\/\/doi.org\/10.1038\/srep25735","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]},"assertion":[{"value":"18 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25735"}}